15^th World Heart Congress

AI-driven cardiovascular diagnostics are transforming clinical decision-making through rapid, accurate, and data-rich insights. Machine learning algorithms analyze ECG patterns, imaging data, biomarkers, and patient histories with remarkable precision, enabling earlier identification of heart disease and subtle abnormalities often missed by conventional methods. Predictive models forecast risks such as arrhythmias, heart failure, and coronary events, supporting more proactive and personalized care plans. AI-enabled imaging enhances detection of structural and functional cardiac changes, reducing workload and improving consistency in interpretation. Real-time diagnostic support tools assist clinicians in emergency and outpatient settings, streamlining workflows and minimizing diagnostic delays. Integration with wearable devices and remote monitoring platforms allows continuous data collection, enabling early alerts for potentially life-threatening conditions. As AI technologies advance, they help close gaps in accessibility, accuracy, and timely interventions. These innovations mark a paradigm shift toward smarter, faster, and more reliable cardiovascular diagnostics that enhance patient outcomes and redefine the future of cardiac assessment.

Smart wearables and remote monitoring technologies are revolutionizing how cardiovascular conditions are tracked, diagnosed, and managed. Devices such as smartwatches, biosensors, and patch-based monitors collect continuous physiological data, offering real-time insights into heart rate, rhythm, oxygen saturation, and activity patterns. These tools empower both patients and clinicians by enabling early identification of arrhythmias, ischemic indicators, and heart failure symptoms outside clinical settings. Cloud-based platforms and AI analytics enhance accuracy, turning raw data into meaningful, actionable information. Remote monitoring reduces hospital visits, supports home-based care, and ensures timely interventions when abnormalities arise. For patients with chronic cardiac conditions, wearables offer reassurance, improved adherence, and personalized feedback that supports long-term heart health. Integration with telemedicine platforms allows physicians to adjust treatments quickly and efficiently. As technology becomes more sophisticated, wearables will evolve into comprehensive, predictive cardiovascular management solutions, redefining continuity of care and strengthening proactive prevention strategies across healthcare systems.

Advances in interventional cardiology continue to elevate precision, safety, and therapeutic success across a wide range of cardiovascular conditions. Innovations in stent technology, catheter-based procedures, and minimally invasive interventions allow effective treatment of complex coronary and structural heart diseases with reduced recovery times. Breakthroughs such as bioresorbable scaffolds, drug-eluting devices, and ultra-thin stents improve long-term vessel healing and reduce complication risks. Transcatheter interventions, including TAVR, TMVR, and left atrial appendage closure, offer life-saving alternatives for high-risk patients who are unsuitable for open-heart surgery. Enhanced imaging and navigation systems support real-time procedural accuracy, improving outcomes and procedural efficiency. Robotic assistance and AI-guided planning further enhance precision while minimizing operator fatigue. As techniques advance, interventional cardiology is expanding its role in preventive and corrective cardiovascular care, offering patients safer, faster, and more personalized treatment options. The ongoing evolution of devices, technologies, and techniques is setting new benchmarks in cardiovascular intervention and transforming modern heart care.

Innovations in heart failure management are reshaping survival, quality of life, and long-term outcomes for millions of patients worldwide. Breakthrough therapies such as SGLT2 inhibitors, novel vasodilators, and advanced neurohormonal modulators optimize cardiac function and slow disease progression. Remote monitoring systems and implantable sensors provide continuous insights into hemodynamic changes, enabling clinicians to modify treatment before symptoms worsen. Mechanical circulatory support devices, including advanced LVADs, provide extended life support for severe cases while offering improved durability and patient mobility. Personalized rehabilitation programs, nutrition strategies, and lifestyle interventions complement medical therapy to strengthen long-term results. Cutting-edge research focuses on regenerative approaches and gene-based therapies aimed at restoring damaged myocardium. Early detection through biomarkers and AI-driven predictive models allows more proactive management, reducing hospitalizations and improving patient stability. Collectively, these advancements represent a new era of heart failure care focused on preventive strategies, personalized treatment, and sustained quality of life.

New insights into hypertension are reshaping prevention and treatment strategies by focusing on early detection, precision therapy, and lifestyle-centered care. Research advancements reveal deeper understanding of genetic predispositions, vascular aging, endothelial dysfunction, and environmental risk factors. Novel antihypertensive medications and combination therapies improve blood pressure control while reducing side effects and improving adherence. Digital health tools, including home monitors and app-based tracking, support continuous monitoring and personalized treatment adjustments. AI-driven models help identify high-risk individuals and predict complications such as stroke, kidney disease, and heart failure. Lifestyle interventions, including dietary optimization, salt reduction, physical activity, and stress management, are becoming more individually tailored through behavioral analytics. Public health initiatives emphasize community awareness and early screening to address the global burden of hypertension. As research progresses, innovative strategies and technology-driven tools continue to refine how hypertension is diagnosed, managed, and prevented, ensuring stronger cardiovascular protection for diverse populations worldwide.

Next-generation cardiac imaging technologies are transforming the accuracy, speed, and depth of cardiovascular assessment. Innovations such as high-resolution MRI, 4D CT, PET-MR fusion, and advanced echocardiography enable detailed visualization of structural and functional abnormalities with unprecedented clarity. AI-powered interpretation tools streamline image analysis, reducing variability and enhancing diagnostic precision. These technologies support earlier detection of coronary plaque, myocardial fibrosis, and subtle ventricular dysfunction, allowing clinicians to intervene before disease progression accelerates. Functional imaging provides deeper insights into perfusion, metabolism, and tissue characterization, improving decision-making for interventions and personalized treatment planning. Non-invasive imaging increasingly replaces invasive procedures for risk assessment, offering faster and safer evaluation for patients. Portable and point-of-care imaging devices expand diagnostic accessibility in remote and emergency settings. As innovation continues, cardiac imaging plays a vital role in advancing precision cardiology, enabling clinicians to diagnose, monitor, and manage heart conditions more effectively than ever before.

Advances in arrhythmia detection and electrophysiology are enhancing diagnostic accuracy, procedural precision, and long-term management of rhythm disorders. Continuous monitoring technologies, including implantable loop recorders, patch devices, and AI-enhanced wearables, detect irregular rhythms earlier and more reliably. Mapping systems with high-density electrodes and real-time visualization offer unparalleled accuracy during ablation procedures. Innovations such as pulsed-field ablation reduce tissue damage, shorten procedure times, and improve safety for atrial fibrillation treatment. Predictive analytics identify individuals at highest risk of arrhythmias, supporting preventive strategies and timely intervention. Genetic screening provides insights into inherited rhythm disorders, enabling personalized treatment plans. Remote device monitoring ensures consistent follow-up for patients with pacemakers and implantable defibrillators, improving outcomes and reducing emergency visits. These advancements collectively enhance the detection, characterization, and treatment of arrhythmias, ensuring more effective rhythm control, reduced complications, and improved quality of life for patients with cardiac electrical disorders.

Robotics and minimally invasive cardiac surgery represent a major leap forward in precision, safety, and recovery for patients requiring complex cardiac interventions. Robotic-assisted platforms enhance surgeon dexterity, offer superior visualization, and enable highly precise manipulation within confined anatomical spaces. Minimally invasive approaches reduce surgical trauma, minimize blood loss, and shorten hospital stays, leading to faster recovery and improved patient comfort. Procedures such as mitral valve repair, coronary artery bypass, and atrial septal defect correction are increasingly performed using robotic systems, providing outcomes comparable to traditional surgery with significantly reduced invasiveness. Enhanced imaging integration and AI-guided navigation further refine procedural accuracy, supporting more predictable results. Training advancements and simulation technologies expand surgeon expertise and promote widespread adoption of these techniques. As robotic technologies evolve, cardiac surgery continues to shift toward safer, more efficient, and patient-centered approaches that align with the future of advanced cardiovascular care.

Regenerative cardiology and stem cell therapies offer transformative potential in repairing damaged heart tissue and restoring cardiac function. Research focuses on harnessing stem cells, biological scaffolds, and gene-based approaches to regenerate myocardium affected by ischemia, infarction, or chronic disease. Advances in induced pluripotent stem cells enable patient-specific cell therapies with reduced rejection risks. Biomaterial innovations support structural integration and enhance cellular survival within damaged tissue. Gene-editing tools such as CRISPR open pathways for correcting inherited cardiac defects at the molecular level. Clinical trials explore combinations of cells, growth factors, and engineered tissues to improve heart performance and reduce the progression of heart failure. While challenges remain in delivery methods and long-term regeneration, progress continues to accelerate. The field promises groundbreaking therapeutic options that move beyond managing symptoms toward actual restoration of cardiac function, offering renewed hope for patients with severe heart disease.

Pediatric and congenital heart disorders require specialized approaches that address unique anatomical, developmental, and physiological needs. Advances in prenatal diagnosis allow early identification of cardiac abnormalities, enabling timely planning for interventions immediately after birth. Minimally invasive surgical techniques and catheter-based corrections significantly reduce risks and recovery times for young patients. Innovations in imaging, including fetal echocardiography and high-resolution MRI, provide clearer assessment of structural and functional defects. Genetic research is uncovering deeper insights into hereditary factors, informing personalized care and family counseling. Long-term management strategies focus on growth, development, and transition into adult congenital care programs. Improved medical therapies support the management of complex conditions such as congenital valve disorders, septal defects, and cyanotic heart disease. As survival rates continue to rise, emphasis on quality of life, mental health, and long-term follow-up becomes increasingly important. These advancements collectively enhance outcomes and provide comprehensive, lifelong support for affected children and their families.

Preventive cardiology and lifestyle medicine prioritize early intervention, personalized risk assessment, and long-term wellness to reduce the global burden of cardiovascular disease. Modern prevention strategies integrate digital health monitoring, genetic risk evaluation, and biomarker profiling to identify individuals at heightened risk before symptoms appear. Lifestyle medicine focuses on clinically proven interventions such as nutrition optimization, physical activity, stress reduction, and sleep improvement to strengthen cardiovascular resilience. Behavioral coaching and digital platforms enhance patient engagement and adherence. Evidence-based guidelines emphasize early management of lipid disorders, obesity, diabetes, and hypertension to prevent progression to severe cardiac conditions. Community-based prevention programs and public health policies support widespread awareness and healthier environments. As preventive cardiology evolves, the emphasis shifts from treating disease to promoting holistic, long-term heart health through proactive, personalized, and sustainable lifestyle strategies that benefit individuals and communities.

Cardiometabolic disorders and obesity significantly increase the risk of heart disease, prompting a growing emphasis on comprehensive, multidisciplinary care. Advances in understanding metabolic dysfunction reveal interconnected pathways linking insulin resistance, inflammation, lipid imbalance, and cardiovascular damage. New pharmacological therapies, including GLP-1 agonists and metabolic modulators, offer powerful tools for managing weight and improving cardiometabolic profiles. Lifestyle interventions addressing nutrition, physical activity, and behavioral psychology remain central to long-term success. Early identification through biomarkers and advanced risk prediction models enables targeted prevention. Obesity’s impact on hypertension, coronary artery disease, heart failure, and arrhythmias highlights the urgency of integrated management approaches. Digital health tools provide ongoing support for weight tracking, glucose monitoring, and personalized coaching. As research expands, the goal is shifting toward precision-based strategies that address the root biological and environmental contributors to metabolic disease, creating more effective pathways for long-term cardiovascular protection.

Women’s heart health research continues to uncover gender-specific risks and presentation patterns that differ significantly from those in men. Hormonal influences, pregnancy-related complications, autoimmune conditions, and unique symptom profiles contribute to underdiagnosis and delayed treatment in many women. Advances in imaging and biomarkers help improve early detection of conditions such as microvascular disease and spontaneous coronary artery dissection. Public awareness initiatives emphasize recognizing atypical symptoms and promoting timely care-seeking behavior. Precision medicine approaches tailor prevention and treatment strategies to female-specific physiology and risk factors. Emerging research explores the effects of menopause, metabolic changes, and stress-related disorders on cardiovascular health. Improved clinical guidelines promote equitable access to care and highlight the importance of specialized screening. As understanding deepens, women’s cardiovascular care continues to evolve toward more accurate diagnosis, targeted treatment, and proactive prevention strategies that address lifelong gender-related risks.

Global cardiovascular health policies and innovations aim to reduce the worldwide burden of heart disease through comprehensive strategies that integrate prevention, treatment, research, and equitable access to care. Public health frameworks emphasize early screening, community education, tobacco control, and improved access to essential medications. Technological advancements such as telemedicine, mobile diagnostics, and AI-driven tools enhance care accessibility in underserved regions. Global collaborations and data-sharing networks support surveillance, risk prediction, and evidence-based policy development. Investments in workforce training and infrastructure strengthen healthcare systems’ ability to manage cardiovascular challenges. Emphasis on sustainable practices and cost-effective interventions ensures long-term impact across diverse populations. As new treatments and digital tools emerge, global cardiovascular health becomes increasingly centered on innovation, equity, and long-term disease prevention. These efforts collectively contribute to healthier populations, reduced disparities, and stronger public health systems worldwide.